Listed

Tempest Therapeutics, Inc.

TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31

Reports and events: 308 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Tempest Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2022-12-2916:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-22-314745
2022-11-0809:02 ET10-QQuarterly reportPeriod 2022-09-300001544227-22-000006
2022-11-0808:55 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001544227-22-000004
2022-09-2316:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-250135
2022-08-1508:10 ET10-QQuarterly reportPeriod 2022-06-300001628280-22-022788
2022-08-1508:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-22-022786
2022-06-2107:31 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-22-177053
2022-06-0908:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-170659
2022-05-2617:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-161149
2022-05-1308:04 ET10-QQuarterly reportPeriod 2022-03-310001628280-22-014231
2022-05-1308:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-22-014229
2022-05-0917:26 ETSC 13DOwnership report, active investor0001193125-22-145151
2022-05-0216:05 ETDEF 14AProxy statementPeriod 2022-06-170001193125-22-136738
2022-05-0208:02 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-135401
2022-04-0121:43 ET10-K/AAnnual report, amendedPeriod 2021-12-310001193125-22-092417
2022-03-2916:57 ET10-KAnnual reportPeriod 2021-12-310001628280-22-007717
2022-03-2916:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-22-007714
2021-12-2316:08 ET8-K5.02 Departure or appointment of officers or directors0001628280-21-025555
2021-11-1016:07 ET10-QQuarterly reportPeriod 2021-09-300001628280-21-022803
2021-11-1015:54 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-022785
2021-09-3010:47 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-21-287569
2021-09-2411:03 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-281694
2021-08-1216:27 ET10-QQuarterly reportPeriod 2021-06-300001193125-21-244745
2021-08-1216:23 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-244725
2021-07-2317:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-223143
2021-07-1616:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-217458
2021-07-1208:51 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-212534
2021-07-0717:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-209988
2021-07-0116:44 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001193125-21-206427
2021-06-2808:51 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-201157
2021-06-2321:10 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-196512
2021-06-1117:21 ET8-K8.01 Other events0001193125-21-189024
2021-05-1307:16 ET10-QQuarterly reportPeriod 2021-03-310001544227-21-000029
2021-04-2916:09 ET10-K/AAnnual report, amendedPeriod 2020-12-310001544227-21-000026
2021-04-1310:06 ETSC 13D/AOwnership report, active investor, amended0001072613-21-000364
2021-03-2907:38 ET10-KAnnual reportPeriod 2020-12-310001544227-21-000018
2021-03-2907:29 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-042768
2021-01-2808:01 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001544227-21-000005
2021-01-0509:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-000639
2020-11-0907:01 ET10-QQuarterly reportPeriod 2020-09-300001544227-20-000045
2020-09-2408:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001544227-20-000042
2020-08-1007:01 ET10-QQuarterly reportPeriod 2020-06-300001544227-20-000039
2020-07-3011:12 ETSC 13D/AOwnership report, active investor, amended0001104659-20-088216
2020-06-2308:36 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-075873
2020-05-0807:36 ET10-QQuarterly reportPeriod 2020-03-310001544227-20-000014
2020-04-2414:59 ETDEF 14AProxy statementPeriod 2020-06-190001544227-20-000008
2020-04-0607:16 ET8-K2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-043387
2020-03-1106:39 ET10-KAnnual reportPeriod 2019-12-310001544227-20-000004
2020-03-0408:37 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-028925
2020-02-1008:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-012871

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.